Skip to content

Clinical evaluation study on the comprehensive program of traditional Chinese medicine to promote the rehabilitation of patients with new coronavirus pneumonia

Clinical evaluation study on the comprehensive program of traditional Chinese medicine to promote the rehabilitation of patients with new coronavirus pneumonia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005439
Enrollment
Unknown
Registered
2021-12-24
Start date
2021-08-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19

Interventions

control group:Modern rehabilitation + Placebo
therapy group:Oral Chinese medicine + Traditional Chinese Medicine Rehabilitation + Modern rehabilitation

Sponsors

Affiliated Hospital of Nanjing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 72 Years

Inclusion criteria

Inclusion criteria: (1) Patients who meet the discharge standards of the "New Coronavirus Pneumonia Diagnosis and Treatment Plan (Eighth Edition)". (2) Asymptomatic patients, or symptomatic patients who meet the diagnostic criteria of lung and spleen qi deficiency syndrome, qi and yin deficiency syndrome, and lung and kidney qi deficiency syndrome in TCM. (3) The age is between 18-70 years old. (4) Informed consent, voluntary test. The process of obtaining informed consent should comply with GCP regulations.

Exclusion criteria

Exclusion criteria: (1) Patients whose new coronavirus pneumonia diagnosis and treatment plan does not meet the discharge standards. (2) Patients with severe primary heart, liver, kidney, blood or diseases that affect their survival. (3) Patients with mental illness, limited cognitive ability, and disabled patients as prescribed by law. (4) Pregnant or lactating women. (5) Those who are known to be allergic to the drugs used in this test.

Design outcomes

Primary

MeasureTime frame
T lymphocyte subsets;Humoral immunity;liver function;Tongue coating;6-minute walk test;Respiratory muscle strength measurement;Depression Self-Rating Scale;antibody test;SF-12 score;chest CT;Self-rating Anxiety Scale;Muscle strength measurement;Pulse condition;Dyspnea scale;Kidney function;

Secondary

MeasureTime frame
Heart rate;blood routine;temperature;blood pressure;urine routine;Respiratory rate;weight;

Countries

china

Contacts

Public ContactShi suofang

Affiliated Hospital of Nanjing University of Chinese Medicine

jsssf2006@126.com+86 13912997691

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026